# C_2020086EN.01000901.xml

| 16.3.2020 | EN | Official Journal of the European Union | C 86/9 |
| --- | --- | --- | --- |

16.3.2020

EN

Official Journal of the European Union

C 86/9

---

Prior notification of a concentration

(Case M.9662 — Generali/Klesia/JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 86/07)

1.

This notification concerns the following undertakings:

| — | Assicurazioni Generali S.p.A. (‘Generali’, Italy), which notably controls Generali Vie S.A. (‘Generali Vie’, France) and |
| --- | --- |

—

Assicurazioni Generali S.p.A. (‘Generali’, Italy), which notably controls Generali Vie S.A. (‘Generali Vie’, France) and

| — | Groupe paritaire de protection sociale Klesia (‘Klesia’, France), which notably controls Klesia Prévoyance, CARCEPT Prévoyance, IPRIAC, and la Mutuelle Klesia Mut’ (all together ‘Klesia Prévoyance’, France). |
| --- | --- |

—

Groupe paritaire de protection sociale Klesia (‘Klesia’, France), which notably controls Klesia Prévoyance, CARCEPT Prévoyance, IPRIAC, and la Mutuelle Klesia Mut’ (all together ‘Klesia Prévoyance’, France).

Generali and Klesia acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control over the pension and collective healthcare business of Generali Vie and the pension and healthcare business of Klesia Prévoyance (the ‘JV’).

The concentration is accomplished by way of contract or any other means.

2.

| — | for Generali: the provision of insurance products for individuals and undertakings — including individual insurance policies, life insurance products as well as insurance policies intended to cover commercial and industrial risks of companies — as well as reinsurance and the distribution of insurance product. |
| --- | --- |

—

for Generali: the provision of insurance products for individuals and undertakings — including individual insurance policies, life insurance products as well as insurance policies intended to cover commercial and industrial risks of companies — as well as reinsurance and the distribution of insurance product.

| — | for Klesia : primarily the provision of life insurance and complementary retirement products. |
| --- | --- |

—

for Klesia : primarily the provision of life insurance and complementary retirement products.

| — | for the JV: the provision of retirement and healthcare products through Generali Vie and Klesia Prévoyance. |
| --- | --- |

—

for the JV: the provision of retirement and healthcare products through Generali Vie and Klesia Prévoyance.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9662 — Generali/Klesia/JV

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---